Index of reports
> Death (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Slow-K (Potassium) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Slow-K side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male, weighing 38.0 kg (83.6 pounds)
Reactions: Cardio-Respiratory Arrest, Lung Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Slow-K
Administration route: Oral
Indication: Hypokalaemia
Start date: 2012-06-06
End date: 2012-06-16
Bisoprolol Fumarate
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Pimobendan
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Sitagliptin Phosphate
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2012-06-06
End date: 2012-06-16
Xarelto
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Start date: 2012-06-06
End date: 2012-06-15
Xarelto
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2012-06-06
End date: 2012-06-15
Lanirapid
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Amiodarone Hydrochloride
Administration route: Oral
Indication: Arrhythmia
Start date: 2012-06-06
End date: 2012-06-16
Diart
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Possible Slow-K side effects in male
Reported by a physician from Japan on 2012-04-16
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Myocardial Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Slow-K
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2010-07-26
Warfarin Sodium
Dosage: 2 mg, qd
Administration route: Oral
Indication: Thrombophlebitis
Start date: 2011-03-01
End date: 2011-06-01
Glyburide
Dosage: 10 mg, qd
Start date: 2009-06-19
End date: 2011-04-14
Hirudoid
Dosage: unk
Indication: Rash
Start date: 2011-07-14
Lidomex
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Riboflavin TAB
Dosage: 60 mg, unk
Administration route: Oral
Indication: Rash
Start date: 2008-11-18
Rinderon-VG
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Ubidecarenone
Dosage: 30 mg, unk
Administration route: Oral
Indication: Oedema Peripheral
Start date: 2008-11-18
Warfarin Sodium
Dosage: 2 mg, unk
Administration route: Oral
Start date: 2011-07-14
Glyburide
Dosage: 7.5 mg, qd
Start date: 2009-05-15
End date: 2009-06-18
Glyburide
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2011-07-15
Candesartan Cilexetil
Dosage: 1.5 df, qd
Indication: Hypertension
Start date: 2004-01-01
End date: 2004-03-08
Coniel
Dosage: 4 mg, qd
Start date: 2007-09-25
End date: 2007-10-21
Kary UNI
Dosage: unk
Indication: Cataract
Start date: 2010-11-16
Loxoprofen
Dosage: 180 mg, unk
Administration route: Oral
Indication: Lumbar Spinal Stenosis
Start date: 2008-11-18
Glyburide
Dosage: 5 mg, qd
Indication: Type 2 Diabetes Mellitus
Start date: 2008-08-28
End date: 2009-05-14
Aspirin
Dosage: 100 mg, qd
Indication: Carotid Arteriosclerosis
Start date: 2004-10-12
Lasix
Dosage: 60 mg, qd
Administration route: Oral
Start date: 2009-12-14
End date: 2010-01-12
Crestor
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-05-26
Pydoxal
Dosage: 90 mg, unk
Administration route: Oral
Start date: 2008-11-18
Limaprost
Dosage: 15 ug, unk
Administration route: Oral
Indication: Osteoarthritis
Start date: 2008-11-18
Vitalfa
Dosage: unk
Indication: Osteoarthritis
Start date: 2008-11-18
Lasix
Dosage: 40 mg, qd
Start date: 2009-10-21
End date: 2009-12-13
Aldecin-AQ
Dosage: unk
Indication: Seasonal Allergy
Start date: 2011-09-16
Urepearl
Dosage: unk
Indication: Tinea Infection
Start date: 2008-11-18
Gentamicin Sulfate
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Antebate
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Artz
Dosage: unk
Indication: Osteoarthritis
Start date: 2008-11-18
Hachimijio-GAN
Dosage: 6.0 g, unk
Administration route: Oral
Indication: Pollakiuria
Start date: 2011-04-06
Glyburide
Dosage: 5.0 mg, qd
Start date: 2011-04-15
End date: 2011-07-14
Candesartan Cilexetil
Dosage: 12 mg, qd
Start date: 2003-03-09
End date: 2011-11-15
Coniel
Dosage: 8 mg, qd
Start date: 2007-10-22
Lasix
Dosage: 80 mg, unk
Administration route: Oral
Start date: 2010-01-13
End date: 2010-07-25
Lasix
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2005-01-10
Lasix
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2010-07-26
End date: 2010-09-28
Lasix
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2010-10-29
Mycospor
Dosage: unk
Indication: Tinea Infection
Start date: 2008-11-18
Mecobalamin
Dosage: 1500 ug, unk
Administration route: Oral
Indication: Osteoarthritis
Start date: 2008-11-18
Urief
Dosage: 8 mg, unk
Administration route: Oral
Indication: Pollakiuria
Start date: 2011-04-06
Placebo
Dosage: unk
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2008-12-15
Lasix
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2010-09-28
End date: 2010-10-28
Ferrous Sulfate TAB
Dosage: 105 mg, unk
Administration route: Oral
Indication: Iron Deficiency Anaemia
Start date: 2008-11-18
Miglitol
Dosage: 100 mg, unk
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-04-16
Lacmarze
Dosage: 600 mg, unk
Administration route: Oral
Indication: Gastritis
Start date: 2008-11-18
Onon
Dosage: 450 mg, unk
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2010-04-16
Candesartan Cilexetil
Dosage: 8 mg, qd
Administration route: Oral
Start date: 2011-11-16
Coniel
Dosage: 2 mg, qd
Indication: Hypertension
Start date: 2004-12-07
End date: 2007-09-24
Lasix
Dosage: 20 mg, qd
Administration route: Oral
Indication: Oedema Peripheral
Start date: 2005-01-11
End date: 2009-10-20
Olopatadine HCL
Dosage: 10 mg, unk
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2008-11-18
Other drugs received by patient: Glimicron; Nespo; Lipitor; Glimicron; Nespo; Metformin HCL; Metformin HCL; Kremezin; Metformin HCL; Glimicron
Possible Slow-K side effects in male
Reported by a physician from Japan on 2012-01-31
Patient: male, weighing 72.0 kg (158.4 pounds)
Reactions: Myocardial Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Glyburide
Dosage: 2.5 mg, unk
Administration route: Oral
Start date: 2011-07-15
Onon
Dosage: 450 mg, unk
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2010-04-16
Candesartan Cilexetil
Dosage: 1.5 df, qd
Indication: Hypertension
Start date: 2004-01-01
End date: 2004-03-08
Aspirin
Dosage: 100 mg, qd
Indication: Carotid Arteriosclerosis
Start date: 2004-10-12
Lasix
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2010-07-26
End date: 2010-09-28
Crestor
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-05-26
Mycospor
Dosage: unk
Indication: Tinea Infection
Start date: 2008-11-18
Mecobalamin
Dosage: 1500 ug, unk
Administration route: Oral
Indication: Osteoarthritis
Start date: 2008-11-18
Limaprost
Dosage: 15 ug, unk
Administration route: Oral
Indication: Osteoarthritis
Start date: 2008-11-18
Ubidecarenone
Dosage: 30 mg, unk
Administration route: Oral
Indication: Oedema Peripheral
Start date: 2008-11-18
Artz
Dosage: unk
Indication: Osteoarthritis
Start date: 2008-11-18
Placebo
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2008-12-15
Slow-K
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hypokalaemia
Start date: 2010-07-26
Candesartan Cilexetil
Dosage: 8 mg, qd
Administration route: Oral
Start date: 2011-11-16
Coniel
Dosage: 2 mg, qd
Indication: Hypertension
Start date: 2004-12-07
End date: 2007-09-24
Coniel
Dosage: 4 mg, qd
Start date: 2007-09-25
End date: 2007-10-21
Kary UNI
Dosage: unk
Indication: Cataract
Start date: 2010-11-16
Glyburide
Dosage: 10 mg, qd
Start date: 2009-06-19
End date: 2011-04-14
Glyburide
Dosage: 5.0 mg, qd
Start date: 2011-04-15
End date: 2011-07-14
Lasix
Dosage: 20 mg, qd
Administration route: Oral
Indication: Oedema Peripheral
Start date: 2005-01-11
End date: 2009-10-20
Lasix
Dosage: 20 mg, unk
Administration route: Oral
Start date: 2010-09-28
End date: 2010-10-28
Aldecin-AQ
Dosage: unk
Indication: Seasonal Allergy
Start date: 2011-09-16
Hachimijio-GAN
Dosage: 6.0 g, unk
Administration route: Oral
Indication: Pollakiuria
Start date: 2011-04-06
Candesartan Cilexetil
Dosage: 12 mg, qd
Start date: 2003-03-09
End date: 2011-11-15
Lasix
Dosage: 10 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2005-01-10
Urief
Dosage: 8 mg, unk
Administration route: Oral
Indication: Pollakiuria
Start date: 2011-04-06
Blinded Aliskiren
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2008-12-15
Loxoprofen
Dosage: 180 mg, unk
Administration route: Oral
Indication: Lumbar Spinal Stenosis
Start date: 2008-11-18
Warfarin Sodium
Dosage: 2 mg, qd
Administration route: Oral
Indication: Thrombophlebitis
Start date: 2011-03-01
End date: 2011-06-01
Glyburide
Dosage: 7.5 mg, qd
Start date: 2009-05-15
End date: 2009-06-18
Lasix
Dosage: 80 mg, unk
Administration route: Oral
Start date: 2010-01-13
End date: 2010-07-25
Lasix
Dosage: 40 mg, unk
Administration route: Oral
Start date: 2010-10-29
Miglitol
Dosage: 100 mg, unk
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-04-16
Pydoxal
Dosage: 90 mg, unk
Administration route: Oral
Start date: 2008-11-18
Rinderon-VG
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Lacmarze
Dosage: 600 mg, unk
Administration route: Oral
Indication: Gastritis
Start date: 2008-11-18
Gentamicin Sulfate
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Warfarin Sodium
Dosage: 2 mg, unk
Administration route: Oral
Start date: 2011-07-14
Urepearl
Dosage: unk
Indication: Tinea Infection
Start date: 2008-11-18
Vitalfa
Dosage: unk
Indication: Osteoarthritis
Start date: 2008-11-18
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiovascular Disorder
Start date: 2008-12-15
Coniel
Dosage: 8 mg, qd
Start date: 2007-10-22
Ferrous Sulfate TAB
Dosage: 105 mg, unk
Administration route: Oral
Indication: Iron Deficiency Anaemia
Start date: 2008-11-18
Riboflavin TAB
Dosage: 60 mg, unk
Administration route: Oral
Indication: Rash
Start date: 2008-11-18
Olopatadine HCL
Dosage: 10 mg, unk
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2008-11-18
Antebate
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Glyburide
Dosage: 5 mg, qd
Indication: Type 2 Diabetes Mellitus
Start date: 2008-08-28
End date: 2009-05-14
Lasix
Dosage: 40 mg, qd
Start date: 2009-10-21
End date: 2009-12-13
Lasix
Dosage: 60 mg, qd
Administration route: Oral
Start date: 2009-12-14
End date: 2010-01-12
Hirudoid
Dosage: unk
Indication: Rash
Start date: 2011-07-14
Lidomex
Dosage: unk
Indication: Rash
Start date: 2008-11-18
Other drugs received by patient: Glimicron; Metformin HCL; Nespo; Metformin HCL; Lipitor; Glimicron; Glimicron; Metformin HCL; Nespo; Kremezin
|